|
COX16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.446200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.594360E-01 |
| Normal-vs-Stage2 |
6.135800E-03 |
| Normal-vs-Stage3 |
1.623040E-03 |
| Normal-vs-Stage4 |
5.310400E-02 |
| Stage1-vs-Stage2 |
7.061700E-02 |
| Stage1-vs-Stage3 |
8.981200E-03 |
| Stage1-vs-Stage4 |
2.765000E-01 |
| Stage2-vs-Stage3 |
6.507200E-01 |
| Stage2-vs-Stage4 |
8.094200E-01 |
| Stage3-vs-Stage4 |
5.725000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.210000E-02 |
| Normal-vs-AfricanAmerican |
1.383150E-01 |
| Normal-vs-Asian |
5.795200E-01 |
| Caucasian-vs-AfricanAmerican |
9.889600E-01 |
| Caucasian-vs-Asian |
8.118000E-01 |
| AfricanAmerican-vs-Asian |
8.392200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.616300E-02 |
| Normal-vs-Female |
8.940100E-02 |
| Male-vs-Female |
9.646800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.228440E-01 |
| Normal-vs-Extreme_Weight |
1.787760E-01 |
| Normal-vs-Obese |
5.270000E-02 |
| Normal-vs-Extreme_Obese |
2.334400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.937000E-01 |
| Normal_Weight-vs-Obese |
8.234000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.791200E-01 |
| Extreme_Weight-vs-Obese |
3.744200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.279400E-01 |
| Obese-vs-Extreme_Obese |
9.688800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.438800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.458550E-01 |
| Normal-vs-Age(61-80Yrs) |
5.075800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.231900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.102200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.303400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.412000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.933800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.108400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.166200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.263000E-01 |
| Normal-VS-Type2 PRCC |
4.31970000003279E-06 |
| Normal-VS-KIRP CIMP |
2.823800E-03 |
| Normal-VS-Unclassified PRCC |
5.994800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.37899749583926E-11 |
| Type1 PRCC-VS-KIRP CIMP |
8.249500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.53272999999787E-05 |
| Type2 PRCC-VS-KIRP CIMP |
6.242600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.180000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.662400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.779400E-03 |
| Normal-vs-N1 |
2.134200E-02 |
| Normal-vs-N2 |
4.138900E-03 |
| N0-vs-N1 |
8.953000E-01 |
| N0-vs-N2 |
1.089390E-01 |
| N1-vs-N2 |
1.228610E-01 |
|
|
